Morphologically distinct subpopulations of neurotensin-immunoreactive striatal neurons observed in rat following dopamine depletions and D2 receptor blockade project to the globus pallidus

Neuroscience

Volumn 74, Issue 3, 1996, Pages 805-812

  Brog, J S ^a   Zahm, D S ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basal ganglia; Globus pallidus; Peptide regulation; Peptides; Striatum

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROPEPTIDE; NEUROTENSIN; RESERPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; GLOBUS PALLIDUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030564965     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00166-2     Document Type: Article

References (45)

1. Anderson K. D., Reiner A. Extensive co-occurrence of substance P and dynorphin in striatal projection neurons: an evolutionarily conserved feature of basal ganglia organization. J. comp. Neurol. 295:1990;339-369.
2. 2 receptor antagonists on proneurotensin mRNA expression in rat striatum. Molec. Brain Res. 9:1991;341-346.
3. Bean A. J., During M. J., Deutch A. Y., Roth R. H. Effects of dopamine depletion on striatal neurotensin: biochemical and immunohistochemical studies. J. Neurosci. 9:1989;4430-4438.
4. Beckstead R. M. Association of D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons. Neuroscience. 27:1988;851-863.
5. Beckstead R. M., Kersey K. S. Immunohistochemical demonstration of differential substance P-, Met-enkephalin-, and glutamic acid decarboxylase-containing cells and axon distributions in the corpus striatum of the cat. J. comp. Neurol. 232:1985;481-498.
6. Brog J. S., Salyapongse A., Deutch A. Y., Zahm D. S. The patterns of afferent innervation of the core and shell in the "accumbens" part of the rat ventral striatum: immunohistochemical detection of retrogradely transported Fluoro-gold. J. comp. Neurol. 338:1993;255-278.
7. Brog J. S., Zahm D. S. Morphology and Fos immunoreactivity reveal two subpopulations of striatal neurotensin neurons following acute 6-hydroxydopamine lesions and reserpine administration. Neuroscience. 65:1995;71-86.
8. Brownstein M. J., Mroz E. A., Tappaz M. L., Leeman S. E. On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra. Brain Res. 135:1977;315-323.
9. Castel M. N., Morino R., Frey P., Terenius L., Hökfelt T. Immunohistochemical evidence for a neurotensin striatonigral pathway in the rat brain. Neuroscience. 55:1993;833-847.
10. De Nadai F., Rovère C., Bidard J.-N., Cuber J.-C., Beaudet A., Kitabgi P. Post-translational processing of the neurotensin/neuromedin N precursor in the central nervous system of the rat - I. Biochemical characterization of maturation products. Neuroscience. 60:1994;159-166.
11. Eggerman K. W., Zahm D. S. Numbers of neurotensin-immunoreactive neurons selectively increased in rat ventral striatum following acute haloperidol administration. Neuropeptides. 11:1988;125-132.
12. Finley J. C. W., Maderdrut J. L., Petrusz P. The immunocytochemical localization of enkephalin in the central nervous system of the rat. J. comp. Neurol. 198:1981;541-565.
13. Frey P., Lis M., Coward D. M. Neurotensin concentrations in rat striatum and nucleus accumbens: further studies of their regulation. Neurochem. Int. 12:1988;33-38.
14. 2 receptors as a major mechanism for the neuroleptic-like action of neurotensin. Ann. N. Y. Acad. Sci. 668:1992;186-204.
15. Gerfen C. R. The neostriatal mosaic: multiple levels of compartmental organization of the basal ganglia. A. Rev. Neurosci. 15:1991;285-320.
16. Gerfen C. R., Engber T. M., Mahan L. C., Susel Z., Chase T. N., Monsma F. J. Jr., Sibley D. R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
17. Gerfen C. R., Young W. S. III Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460:1988;161-167.
18. Heimer L., Zahm D. S. and Alheid G. F. (1995) Basal ganglia. In The Rat Nervous System (ed. Paxinos G.), pp. 579-628. Academic Press, Sydney.
19. Hong J. S., Yang H.-Y. T., Costa E. Projections of substance P containing neurons from neostriatum to substantia nigra. Brain Res. 121:1977;541-544.
20. Kanazawa I., Emson P. C., Emson A. C. Evidence for the existence of substance P-containing fibers in the striato-nigral and pallido-nigral pathways in rat brain. Brain Res. 119:1977;447-453.
21. Kawaguchi Y., Wilson C. J., Emson P. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J. Neurosci. 10:1990;3421-3438.
22. Kita H., Kitai S. T. Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations. Brain Res. 447:1988;346-352.
23. Le Moine C., Normand E., Bloch B. Phenotypical characterization of rat striatal neurons expressing the D1 dopamine receptor gene. Proc. natn. Acad. Sci. U.S.A. 88:1991;4205-4209.
24. Le Moine C., Normand E., Guitteny A. F., Fouque B., Teoule R., Bloch B. Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. natn. Acad. Sci. U.S.A. 87:1990;230-234.
25. Merchant K. M., Dobie D. J., Dorsa D. M. Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs. Ann. N. Y. Acad. Sci. 668:1992;652-653.
26. Merchant K. M., Dobner P. R., Dorsa D. M. Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum. J. Neurosci. 12:1992;652-663.
27. Merchant K. M., Dorsa D. M. Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc. natn. Acad. Sci. U.S.A. 90:1993;3447-3451.
28. Merchant K. M., Hanson G. R., Dorsa D. M. Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute halperidol effects. J. Pharmac. exp. Ther. 269:1994;806-812.
29. Merchant K. M., Miller M. A. Coexpression of neurotensin and c-fos mRNAs in rat neostriatal neurons following acute haloperidol. Molec. Brain Res. 23:1994;271-277.
30. 1 dopamine receptor-activated c-fos. Brain Res. 523:1990;288-290.
31. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience. 49:1992;285-296.
32. 1 dopamine receptor agonists selectively activate striatal c-fos independent of rotational behavior. Brain Res. 503:1989;346-349.
33. Senger B., Brog J. S., Zahm D. S. Subsets of neurotensin immunoreactive neurons in the rat striatal complex following antagonism of the dopamine D-2 receptor: an immunohistochemical double-labeling study using antibodies against Fos. Neuroscience. 57:1993;649-660.
34. Staines W. A., Nagy J. I., Vincent S. R., Fibiger H. C. Neurotransmitters contained in the efferents of the striatum. Brain Res. 194:1980;391-402.
35. Sugimoto T., Mizuno N. Immunohistochemical demonstration of neurotensin in striatal neurons of the cat, with particular reference to coexistence with enkephalin. Brain Res. 398:1986;195-198.
36. Sugimoto T., Mizuno N. Neurotensin in projection neurons of the striatum and nucleus accumbens, with reference to coexistence with enkephalin and GABA: an immunohistochemical study in the cat. J. comp. Neurol. 257:1987;383-395.
37. Trugman J. M., Wooten G. F. Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions. J. Neurosci. 7:1987;2927-2935.
38. Vincent S. R., Hökfelt T., Christenson I., Terenius L. Immunohistochemical evidence for a dynorphin immunoreactive striatonigral pathway. Eur. J. Pharmac. 85:1982;251-252.
39. Wooten G. F., Collins R. C. Metabolic effects of unilateral lesion of the substantia nigra. J. Neurosci. 1:1981;285-291.
40. Woulfe J., Lafortune L., De Nadai F., Kitabgi P., Beaudet A. Post-translational processing of the neurotensin/neuromedin N precursor in the central nervous system of the rat - II. Immunohistochemical localization of maturation products. Neuroscience. 60:1994;167-181.
41. Zahm D. S. Distinct subsets of neurotensin immunoreactive neurons revealed following antagonism of the dopamine-mediated suppression of neurotensin immunoreactivity in the rat striatum. Neuroscience. 46:1992;335-350.
42. Zahm D. S., Johnson S. N. Asymmetrical distribution of neurotensin immunoreactivity in the basal ganglia of the rat following unilateral injections of 6-hydroxydopamine into the ventral tegmental area of Tsai. Brain Res. 483:1989;301-311.
43. Zahm D. S., Williams E. S., Poulad D., Krause J. E. Non-isotopic in situ hybridization using digoxigenin-labeled riboprobes against neurtensin/neuromedin N mRNA: a time course study in rat striatum following administration of haloperidol. Neuroscience. 00:1996;000-000.
44. Zahm D. S., Williams E. S., Senger B. EM morphometry reveals that neurotensin immunoreactivity is elicited in different subpopulations of striatal axons following dopamine D-2 receptor antagonist and reserpine administration. Soc. Neurosci. Abstr. 21:1995;1907.
45. Zamir N., Palkovitz M., Weber E., Mezey E., Brownstein M. J. A dynorphinergic pathway of leu-enkephalin production in rat substantia nigra. Nature. 307:1984;643-645.